Navigation Links
Hospira to Present at Upcoming Investor Conferences
Date:2/14/2011

LAKE FOREST, Ill., Feb. 14, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that the company will present at two upcoming conferences:


  • Raymond James 32nd Institutional Investors Conference


  • March 8, 2011 (Tuesday) – Orlando, Fla.  9:15 a.m. Eastern time


  • Barclays Capital 2011 Global Healthcare Conference


  • March 16, 2011 (Wednesday) – Miami, Fla.:45 a.m. Eastern timeThe presentations will be available to all interested parties through live audiocasts accessible via the investor relations section of Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance of each presentation to ensure proper setup to receive the audiocast. The slides accompanying the presentations will also be available on the Hospira Web site. Replays of the webcasts will be available on the Hospira Web site approximately 24 hours after the live presentations.

    Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.


    '/>"/>
    SOURCE Hospira, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1

    Related medicine technology :

    1. Hospira Announces FDA Approval of Topotecan Injection
    2. Hospira Reports Fourth-Quarter and Full-Year 2010 Results
    3. Hospira to Host Conference Call for Fourth-Quarter 2010 Results and 2011 Projections
    4. Hospira Launches Piperacillin and Tazobactam for Injection in the United States
    5. Hospira Announces New Contracts in Effect with Novation for Infusion Pumps, Solutions and Equipment
    6. Hospira to Host Conference Call for Third-Quarter 2010 Results
    7. Hospira Receives TGA Approval for Nivestim™, Australias First Biosimilar Filgrastim
    8. Hospira Japan Receives Approval for New Indication for Precedex IV™ 200ug
    9. Hospira Announces CEO Succession Plan
    10. Hospira to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Aug. 12
    11. Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/18/2017)... PAUL, Minn. , Jan. 18, 2017 /PRNewswire-USNewswire/ ... developer of medical devices using neuroblocking technology to ... today announced the pricing of an underwritten public ... million, prior to deducting underwriting discounts and commissions ... The offering is comprised of Class A Units, ...
    (Date:1/18/2017)... SAN JOSE, Calif. , Jan. 18, 2017  Adaptive ... machines, announced today a new partnership with Hyatt Place ... guests by providing ASTI LectroFan sleep therapy machines in ... "Obviously one of the most important parts of having ... Wicks , general manager of Hyatt Place Nashville/Downtown. "We,re ...
    (Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
    Breaking Medicine Technology:
    (Date:1/19/2017)... ... ... Allegheny Health Network (AHN) officials today announced a bold new step to greatly ... in the greater Pittsburgh region. Starting January 23, patients who call AHN by 11 ... afternoon. , AHN is the first healthcare provider in the region ...
    (Date:1/19/2017)... GA (PRWEB) , ... January 19, 2017 , ... ... offers asset protection and financial planning services to communities throughout eastern Georgia, is ... fight against heart disease. , Heart disease kills more Americans every year than ...
    (Date:1/19/2017)... ... January 19, 2017 , ... For the third year running, ... and the surrounding area, is inaugurating a charity event to help raise ... as Lou Gehrig's disease or motor neurone disease, is a deadly neurological disorder ...
    (Date:1/19/2017)... ... ... Attorney Robert “RC” Pate , founder of The Law Office of ... Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric cancers. In 2006, ... of the critical funding gap for research into pediatric cancer research. From 2006 onwards, ...
    (Date:1/19/2017)... ... 19, 2017 , ... For the second consecutive year, all ... (RMACT) have earned “Top Doctor” awards. Dr. Mark Leondires, Dr. Spencer Richlin, Dr. ... chosen by their peers for the 2017 list based on their exceptional patient ...
    Breaking Medicine News(10 mins):